✦ LIBER ✦

Long term outcome of patients with hairy cell leukemia treated with pentostatin

✍ Scribed by Patricia Ribeiro; Fadhela Bouaffia; Pierre-Yves Peaud; Michel Blanc; Bruno Salles; Gilles Salles; Bertrand Coiffier

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 107 KB
Volume: 85
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19990101)85:1<65::aid-cncr9>3.0.co;2-b

No coin nor oath required. For personal study only.

✦ Synopsis

BACKGROUND.

With the introduction of new drugs such as interferon-␣ (IFN) and purine analogs, the management of hairy cell leukemia (HCL) patients has changed. However, pentostatin has been found to produce higher complete remission rates than IFN. The current study was undertaken to investigate response and long term follow-up in HCL patients treated with pentostatin.

📜 SIMILAR VOLUMES

Successful treatment of a patient with h

Successful treatment of a patient with hairy cell leukemia and pentostatin-induced autoimmune thrombocytopenia with rituximab

✍ Manfred Hensel; Anthony D. Ho 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

Surface immunoglobulins on hairy cells o

Surface immunoglobulins on hairy cells of 55 patients with hairy cell leukemia

✍ Harvey M. Golomb; Susan Davis; Carol Wilson; James Vardiman 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB

Long-term outcome of patients with intra

Long-term outcome of patients with intraspinal neuroblastoma

✍ Hoover, Margo; Bowman, Laura C.; Crawford, Susan E.; Stack, Cynthia; Donaldson, 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Background. Chemotherapy, radiotherapy, and surgical decompression with laminectomy are effective therapeutic options in the treatment of cord compression from neuroblastoma (NB). We report the long-term outcome of patients with intraspinal NB treated with or without laminectomy at two large pediatr

Long-term remission in an elderly patien

Long-term remission in an elderly patient with mantle cell leukemia treated with low-dose cyclophosphamide

✍ Asou, Norio; Suzushima, Hitoshi; Nishimura, Shintaro; Okubo, Toshiya; Yamasaki, 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

We present an elderly patient with mantle cell leukemia who was successfully treated with low-dose cyclophosphamide (CY). A 76-year-old female was diagnosed as mantle cell leukemia based on abnormal lymphocytosis and splenomegaly without lymphadenopathy. She was orally treated with 50 mg of CY daily

DOES AGE PREDICT THE LONG-TERM OUTCOME O

DOES AGE PREDICT THE LONG-TERM OUTCOME OF DEPRESSION TREATED WITH ECT? (A PROSPECTIVE STUDY OF THE LONG-TERM OUTCOME OF ECT-TREATED DEPRESSION WITH RESPECT TO AGE)

✍ MICHAEL L. WESSON; ANDREW M. WILKINSON; DAVID N. ANDERSON; CHERIE McCRACKEN 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

Sixty-three subjects with DSM-III-R major depression with melancholia or psychosis were followed up 2±4 years after index treatment with electroconvulsive therapy. There was a twofold increase in likelihood of improved outcome with an additional 20 years of age.

Small cell carcinoma of the bladder : Lo

Small cell carcinoma of the bladder : Long term outcome with integrated chemoradiation

✍ Caroline Lohrisch; Nevin Murray; Tom Pickles; Lorne Sullivan 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## BACKGROUND. Small cell carcinoma of the bladder (SCCB) is an uncommon tumor with approximately 8% 5-year survival reported in the literature for patients with disease confined to the pelvis. It exhibits biologic behavior similar to that of small cell carcinoma of the lung (SCLC). The authors so